BELL therapeutics

BELL therapeutics

Uses innovative biotechnology to develop next-generation treatments that are more customized, accessible, and effective.

HQ location
Seoul, South Korea
Launch date
Employees
Company register number
8168702670
  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor investor investor

€0.0

round
*

N/A

Grant
Total Funding000k
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads